Nicola Orofino

Legnano, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications

Second attempt to discontinue TKI after molecular relapse in patients with chronic myeloid leukemia: A real-life Italian multicenter study.

Second attempt to discontinue TKI after molecular relapse in patients with chronic myeloid leukemia: A real-life Italian multicenter study.

Journal: Cancer
Published: November 16, 2025

Clinical Outcomes of Ruxolitinib Treatment in Patients With IPSS Intermediate-1-Risk Myelofibrosis: Interim Analysis From an Italian, Prospective Study (ROMEI).

Clinical Outcomes of Ruxolitinib Treatment in Patients With IPSS Intermediate-1-Risk Myelofibrosis: Interim Analysis From an Italian, Prospective Study (ROMEI).

Journal: Hematological oncology
Published: November 13, 2025

Dosing and clinical outcomes of ruxolitinib in patients with myelofibrosis in a real-world setting: Interim results of the Italian observational study (ROMEI).

Dosing and clinical outcomes of ruxolitinib in patients with myelofibrosis in a real-world setting: Interim results of the Italian observational study (ROMEI).

Journal: Cancer
Published: October 24, 2024

Direct determination of chronic myeloid leukemia prevalence in Lombardy-Italy: Global implications.

Direct determination of chronic myeloid leukemia prevalence in Lombardy-Italy: Global implications.

Journal: Hematological oncology
Published: August 09, 2024

Bosutinib Treatment of Chronic Myeloid Leukemia in Lombardy.

Bosutinib Treatment of Chronic Myeloid Leukemia in Lombardy.

Journal: Acta haematologica
Published: April 28, 2024

Prospective assessment of NGS-detectable mutations in CML patients with nonoptimal response: the NEXT-in-CML study.

Prospective assessment of NGS-detectable mutations in CML patients with nonoptimal response: the NEXT-in-CML study.

Journal: Blood
Published: August 23, 2019

Integrating clinical, morphological, and molecular data to assess prognosis in patients with primary myelofibrosis at diagnosis: A practical approach.

Integrating clinical, morphological, and molecular data to assess prognosis in patients with primary myelofibrosis at diagnosis: A practical approach.

Journal: Hematological oncology
Published: June 23, 2019

Deferasirox in the management of iron-overload in patients with myelofibrosis: a multicentre study from the Rete Ematologica Lombarda (IRON-M study).

Deferasirox in the management of iron-overload in patients with myelofibrosis: a multicentre study from the Rete Ematologica Lombarda (IRON-M study).

Journal: British journal of haematology
Published: May 21, 2019

Outcome of very elderly chronic myeloid leukaemia patients treated with imatinib frontline.

Outcome of very elderly chronic myeloid leukaemia patients treated with imatinib frontline.

Journal: Annals of hematology
Published: April 16, 2019

Epidemiology and treatment approaches in management of invasive fungal infections in hematological malignancies: Results from a single-centre study.

Epidemiology and treatment approaches in management of invasive fungal infections in hematological malignancies: Results from a single-centre study.

Journal: PloS one
Published: November 10, 2018

Lymphocytic variant hypereosinophilia: a challenging diagnosis of a rare disease with pleomorphic clinical picture.

Lymphocytic variant hypereosinophilia: a challenging diagnosis of a rare disease with pleomorphic clinical picture.

Journal: European journal of internal medicine
Published: July 26, 2018

Low-Dose Ponatinib in Intolerant Chronic Myeloid Leukemia Patients: A Safe and Effective Option.

Low-Dose Ponatinib in Intolerant Chronic Myeloid Leukemia Patients: A Safe and Effective Option.

Journal: Clinical drug investigation
Published: January 25, 2018
Showing 1-12 of 36

Last Updated: 09/26/2026